ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ABCL AbCellera Biologics Inc

3.675
-0.225 (-5.77%)
Last Updated: 14:51:37
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,488,567
Bid Price 3.67
Ask Price 3.68
News -
Day High 3.8799

Low
3.62

52 Week Range

High
8.05

Day Low 3.62
Company Name Stock Ticker Symbol Market Type
AbCellera Biologics Inc ABCL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.225 -5.77% 3.675 14:51:37
Open Price Low Price High Price Close Price Prev Close
3.86 3.62 3.8799 3.90
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
8,673 1,488,567 $ 3.70 $ 5,514,788 - 3.62 - 8.05
Last Trade Time Type Quantity Stock Price Currency
14:52:00 1 $ 3.675 USD

AbCellera Biologics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.06B 289.36M - 38.03M -146.4M -0.51 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

AbCellera Biologics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ABCL Message Board. Create One! See More Posts on ABCL Message Board See More Message Board Posts

Historical ABCL Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.954.313.623.931,202,728-0.275-6.96%
1 Month4.514.74993.624.231,084,257-0.835-18.51%
3 Months5.175.463.624.761,370,266-1.50-28.92%
6 Months4.396.0553.624.871,433,867-0.715-16.29%
1 Year7.108.053.625.821,945,435-3.43-48.24%
3 Years29.5536.053.6210.611,981,894-25.88-87.56%
5 Years61.0071.913.6212.431,890,053-57.33-93.98%

AbCellera Biologics Description

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Your Recent History

Delayed Upgrade Clock